| Symbol |
Name |
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
ANKRD6
|
ankyrin repeat domain 6
|
|
ANXA2
|
annexin A2
|
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP5
|
aquaporin 5
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATF4
|
activating transcription factor 4
|
|
ATM
|
ATM serine/threonine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCR
|
breakpoint cluster region
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CDC25C
|
cell division cycle 25C
|
|
CDCA5
|
cell division cycle associated 5
|
|
CDCA8
|
cell division cycle associated 8
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLDN1
|
claudin 1
|
|
CLDN5
|
claudin 5
|
|
CLDN7
|
claudin 7
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTTN
|
cortactin
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DMTN
|
dematin actin binding protein
|
|
DNM2
|
dynamin 2
|
|
DOK2
|
docking protein 2, 56kDa
|
|
ECT2
|
epithelial cell transforming 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G3
|
eukaryotic translation initiation factor 4 gamma, 3
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
EZR
|
ezrin
|
|
FGF10
|
fibroblast growth factor 10
|
|
FHIT
|
fragile histidine triad
|
|
FLCN
|
folliculin
|
|
FLNA
|
filamin A, alpha
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GOLGA2
|
golgin A2
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H2AFX
|
H2A histone family, member X
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGN2
|
high mobility group nucleosomal binding domain 2
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HSF1
|
heat shock transcription factor 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL33R
|
interleukin 33 receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
JUN
|
jun proto-oncogene
|
|
KRT8
|
keratin 8, type II
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LIME1
|
Lck interacting transmembrane adaptor 1
|
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1
|
|
LTA4H
|
leukotriene A4 hydrolase
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MINK1
|
misshapen-like kinase 1
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MSN
|
moesin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYLK
|
myosin light chain kinase
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NEK9
|
NIMA-related kinase 9
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPA
|
natriuretic peptide A
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARD6A
|
par-6 family cell polarity regulator alpha
|
|
PCYT1A
|
phosphate cytidylyltransferase 1, choline, alpha
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PHF20
|
PHD finger protein 20
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PKDCC
|
protein kinase domain containing, cytoplasmic
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD2
|
phospholipase D2
|
|
PML
|
promyelocytic leukemia
|
|
POLDIP3
|
polymerase (DNA-directed), delta interacting protein 3
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PXN
|
paxillin
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RALBP1
|
ralA binding protein 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RDX
|
radixin
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD5
|
SMAD family member 5
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK38L
|
serine/threonine kinase 38 like
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TBX21
|
T-box 21
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TJP1
|
tight junction protein 1
|
|
TLK1
|
tousled-like kinase 1
|
|
TNS3
|
tensin 3
|
|
TP53
|
tumor protein p53
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
|
TSC2
|
tuberous sclerosis 2
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZFP36
|
ZFP36 ring finger protein
|
